HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS INFECTION trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to clear hepatitis b in HIV patients
Disease control OngoingThis study tests a new drug called bepirovirsen in 153 people who have both HIV and chronic hepatitis B and are already on HIV treatment. The goal is to see if bepirovirsen can clear the hepatitis B virus from the body better than a placebo. Participants will continue their regul…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to improve cervical cancer detection for women with HIV
Diagnosis OngoingThis study looks at different methods to find early signs of cervical cancer in women living with HIV in the Dominican Republic. The goal is to see which screening approach works best to catch abnormal cells caused by HPV. About 619 women aged 25-49 will take part, helping doctor…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Shingles vaccine safety in pregnancy under review for immunocompromised women
Knowledge-focused OngoingThis study looks at whether the shingles vaccine (HZ/su) is safe for pregnant women aged 18-49 with weakened immune systems. Researchers will track about 2,800 women to see if the vaccine raises the risk of birth defects or other problems in their babies. The goal is to provide r…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC